Search Results - "Dransfield, M T"

Computed tomographic measures of airway morphology in smokers and never-smoking normals by Washko, G R, Diaz, A A, Kim, V, Barr, R G, Dransfield, M T, Schroeder, J, Reilly, J J, Ramsdell, J W, McKenzie, A, Van Beek, E J R, Lynch, D A, Butler, J P, Han, M K

“…Bronchial wall area percent (WA% = 100 × wall area/total bronchial cross sectional area) is a standard computed tomographic (CT) measure of central airway…”
Get full text

Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD by Dransfield, M T, Rowe, S M, Johnson, J E, Bailey, W C, Gerald, L B

“…Cardiovascular disease is a major cause of death in patients with chronic obstructive pulmonary disease (COPD) and predicts hospitalisation for acute…”
Get more information

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease by Mkorombindo, Takudzwa, Dransfield, Mark T

“…Despite maximal medical therapy, a subset of patients with chronic obstructive pulmonary disease continue to suffer acute exacerbations. It is also clear that…”
Get full text

The Association Between Neighborhood Socioeconomic Disadvantage and Chronic Obstructive Pulmonary Disease by Galiatsatos, Panagis, Woo, Han, Paulin, Laura M, Kind, Amy, Putcha, Nirupama, Gassett, Amanda J, Cooper, Christopher B, Dransfield, Mark T, Parekh, Trisha M, Oates, Gabriela R, Barr, R Graham, Comellas, Alejandro P, Han, Meilan K, Peters, Stephen P, Krishnan, Jerry A, Labaki, Wassim W, McCormack, Meredith C, Kaufman, Joel D, Hansel, Nadia N

“…Individual socioeconomic status has been shown to influence the outcomes of patients with chronic obstructive pulmonary disease (COPD). However, contextual…”
Get full text

Life-Space mobility and clinical outcomes in COPD by Iyer, Anand S, Wells, James M, Bhatt, Surya P, Kirkpatrick, deNay P, Sawyer, Patricia, Brown, Cynthia J, Allman, Richard M, Bakitas, Marie A, Dransfield, Mark T

“…Social isolation is a common experience in patients with COPD but is not captured by existing patient-reported outcomes, and its association with clinical…”
Get full text

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis by Barjaktarevic, Igor Z, Buhr, Russell G, Wang, Xiaoyan, Hu, Scott, Couper, David, Anderson, Wayne, Kanner, Richard E, Paine Iii, Robert, Bhatt, Surya P, Bhakta, Nirav R, Arjomandi, Mehrdad, Kaner, Robert J, Pirozzi, Cheryl S, Curtis, Jeffrey L, O'Neal, Wanda K, Woodruff, Prescott G, Han, MeiLan K, Martinez, Fernando J, Hansel, Nadia, Wells, James Michael, Ortega, Victor E, Hoffman, Eric A, Doerschuk, Claire M, Kim, Victor, Dransfield, Mark T, Drummond, M Bradley, Bowler, Russell, Criner, Gerard, Christenson, Stephanie A, Ronish, Bonnie, Peters, Stephen P, Krishnan, Jerry A, Tashkin, Donald P, Cooper, Christopher B

“…Bronchodilator responsiveness (BDR) is prevalent in COPD, but its clinical implications remain unclear. We explored the significance of BDR, defined by…”
Get full text

Determinants of successful completion of pulmonary rehabilitation in COPD by Brown, Angel T, Hitchcock, Jason, Schumann, Christopher, Wells, J Michael, Dransfield, Mark T, Bhatt, Surya P

“…Despite known benefits, a significant proportion of patients with COPD do not complete pulmonary rehabilitation (PR). Little is known regarding which factors…”
Get full text

A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD by Bhatt, Surya P, Dransfield, Mark T, Cockcroft, John R, Wang-Jairaj, Jie, Midwinter, Dawn A, Rubin, David B, Scott-Wilson, Catherine A, Crim, Courtney

“…Chronic obstructive pulmonary disease (COPD) is associated with increased cardiovascular morbidity and mortality. Elevated arterial stiffness, measured by…”
Get full text

The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study by Gulati, Swati, Zouk, Aline N, Kalehoff, Jonathan P, Wren, Christopher S, Davison, Peter N, Kirkpatrick, Denay Porter, Bhatt, Surya P, Dransfield, Mark T, Wells, James Michael

“…Systemic corticosteroids (SC) are an integral part of managing acute exacerbations of COPD (AECOPD). However, the optimal dose and duration vary widely in…”
Get full text

Velocity Transfer Function In The Right Pulmonary Artery And Impaired Cardiopulmonary Reserve In COPD by Sharifov, Oleg F, Denney, Jr, Thomas S, Wells, J Michael, Payne, Gregory A, Gulati, Swati, Gupta, Himanshu, Dransfield, Mark T, Lloyd, Steven G

“…Oleg F Sharifov,1 Thomas S Denney Jr,2 J Michael Wells,1,3,4 Gregory A Payne,1,4 Swati Gulati,1,3 Himanshu Gupta,5 Mark T Dransfield,1,3,4 Steven G Lloyd1,4…”
Get full text

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum] by Barjaktarevic, Igor, Buhr, Russell G, Wang, Xiaoyan, Hu, Scott, Couper, David, Anderson, Wayne, Kanner, Richard E, Paine III, Robert, Bhatt, Surya P, Bhakta, Nirav R, Arjomandi, Mehrdad, Kaner, Robert J, Pirozzi, Cheryl S, Curtis, Jeffrey L, O'Neal, Wanda K, Woodruff, Prescott G, Han, MeiLan K, Martinez, Fernando J, Hansel, Nadia, Wells, James Michael, Ortega, Victor E, Hoffman, Eric, Doerschuk, Claire M, Kim, Victor, Dransfield, Mark T, Drummond, M Bradley, Bowler, Russell, Criner, Gerard, Christenson, Stephanie A, Ronish, Bonnie, Peters, Stephen, Krishnan, Jerry A, Tashkin, Donald, Cooper, Christopher

“…Funding This study was supported by R01HL125432-01A1 (MBD), T32HL007106-41 (RMB), and TL1TR001883-01 (RGB). SPIROMICS was supported by contracts from the…”
Get full text

Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort by Cooper, Christopher B, Paine, Robert, Curtis, Jeffrey L, Kanner, Richard E, Martinez, Carlos H, Meldrum, Catherine A, Bowler, Russell, O'Neal, Wanda, Hoffman, Eric A, Couper, David, Quibrera, Miguel, Criner, Gerald, Dransfield, Mark T, Han, MeiLan K, Hansel, Nadia N, Krishnan, Jerry A, Lazarus, Stephen C, Peters, Stephen P, Barr, R Graham, Martinez, Fernando J, Woodruff, Prescott G

“…Some COPD patients develop extreme breathlessness, decreased exercise capacity and poor health status yet respiratory disability is poorly characterized as a…”
Get full text

Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD by Cuttica, Michael J, Bhatt, Surya P, Rosenberg, Sharon R, Beussink, Lauren, Shah, Sanjiv J, Smith, Lewis J, Dransfield, Mark T, Kalhan, Ravi

“…The ratio of the diameter of the pulmonary artery (PA) to the diameter of the aorta (PA:A) on computed tomography (CT) imaging is associated with both COPD…”
Get full text

Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD by Criner, Gerard J, Connett, John E, Aaron, Shawn D, Albert, Richard K, Bailey, William C, Casaburi, Richard, Cooper, J. Allen D, Curtis, Jeffrey L, Dransfield, Mark T, Han, MeiLan K, Make, Barry, Marchetti, Nathaniel, Martinez, Fernando J, Niewoehner, Dennis E, Scanlon, Paul D, Sciurba, Frank C, Scharf, Steven M, Sin, Don D, Voelker, Helen, Washko, George R, Woodruff, Prescott G, Lazarus, Stephen C

“…In this study involving patients who were at high risk for exacerbations of chronic obstructive pulmonary disease but had no other indication for statin…”
Get full text

COPD and multimorbidity: recognising and addressing a syndemic occurrence by Fabbri, Leonardo M, Celli, Bartolome R, Agustí, Alvar, Criner, Gerard J, Dransfield, Mark T, Divo, Miguel, Krishnan, Jamuna K, Lahousse, Lies, Montes de Oca, Maria, Salvi, Sundeep S, Stolz, Daiana, Vanfleteren, Lowie E G W, Vogelmeier, Claus F

“…Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe…”
Get full text

A32 ADAPTIVE IMMUNITY IN LUNG DISEASE: Longitudinal Changes In Proportions Of Regulatory T Cell And Myeloid Cell Populations Following Bronchial Thermoplasty by Trevor, J, Zhi, D, Wang, F, Dransfield, M T, Curtiss, M, Deshane, J

Get full text

Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial by Rowe, Steven M, Jones, Ieuan, Dransfield, Mark T, Haque, Nazmul, Gleason, Stephen, Hayes, Katy A, Kulmatycki, Kenneth, Yates, Denise P, Danahay, Henry, Gosling, Martin, Rowlands, David J, Grant, Sarah S

“…Excess mucus plays a key role in COPD pathogenesis. Cigarette smoke-induced cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction may…”
Get full text

B23 WHEN I GET HOME: CONFRONTING THE CHALLENGES OF COPD EXACERBATION: Risk Factors For COPD Exacerbations In Inhaled Medication Users: COPDgene Study Biannual Longitudinal Follow-Up by Busch, R, Bowler, R P, Han, M K, Dransfield, M T, Hersh, C P

Get full text

B108 BEYOND WHO GROUP I PULMONARY HYPERTENSION: Acquired Cftr Dysfunction And Pulmonary Arterial Enlargement In Chronic Obstructive Pulmonary Disease by Teerapuncharoen, K, Wells, J M, Dransfield, M T, Rowe, S M

Get full text

A23 NOT A SECOND TIME: SOLUTIONS TO COPD READMISSIONS AND CARE MANAGEMENT: A Novel Approach To Reducing 90-Day Readmission Rates For Patients With AeCOPD by Kirkpatrick, D P, Wells, J M, Bhatt, S P, Tucker, R, Leach, L, Dransfield, M T

Get full text